Trademark: ANJESO (MELOXICAM) INJECTION
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
ANJESO (MELOXICAM) INJECTION
Click here to search for trademarks similar to ANJESO (MELOXICAM) INJECTION
Proof of use for ANJESO (MELOXICAM) INJECTION
We do not have any records of a proof of use for ANJESO (MELOXICAM) INJECTION at this moment.
Click here to add a proof of use for ANJESO (MELOXICAM) INJECTION
Possible trademark infringements of ANJESO (MELOXICAM) INJECTION
Basic Information about ANJESO (MELOXICAM) INJECTION
- Serial Number
- 88174417
- Filing Date
- 30 Oct 2018
- Registration Number
- 6080999
- Registration Date
- 16 Jun 2020
- Mark Drawing Code
- 5
Classifications
Declare the trademark use of ANJESO (MELOXICAM) INJECTION on the blockchain with WikiTrademarks.io.
- First use of ANJESO (MELOXICAM) INJECTION anywhere
- ANJESO (MELOXICAM) INJECTION was first used on 20 Feb 2020 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns ANJESO (MELOXICAM) INJECTION?
1. BAUDAX BIO, INC. MALVERN PA
2. BAUDAX BIO, INC. MALVERN PA
3. Recro Pharma, Inc. Malvern PA
4. Recro Pharma, Inc. Malvern PA
Correspondent
- Lori Harrison
- TROUTMAN PEPPER HAMILTON SANDERS LLP
- 875 Third Avenue
- New York NY 10022
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io